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Chronic postoperative endophthalmitis (CPE) is a delayed infectious intraocular inﬂammation process that occurs more than
six weeks after ocular surgery and frequently masquerades as autoimmune uveitis. These cases are at risk of delayed diagnosis
and erroneous long-term treatment with corticosteroids. This paper aims to review the epidemiology, microbiology, clinical cha-
racteristics, diagnosis, management strategies, and outcome of chronic postoperative endophthalmitis. The incidence of CPE is
still uncommon, and multiple pathogens have been reported with varying frequencies. Review of the literature reveals that CPE
cases have a high incidence of visual impairment and recurrence rate might be decreased with aggressive surgical approach.
1.IntroductionandDeﬁnitions
Endophthalmitis is an uncommon but sight-threatening in-
traocular inﬂammation that may be due to a noninfectious
process or may be caused by an infectious organism. It is a
term used to describe intraocular inﬂammation that involves
the vitreous cavity and the anterior chamber of the eye and
can involve other adjacent ocular tissues such as the choroid
or retina, sclera or cornea [1]. In infectious endophthalmitis,
the organism might reach the eye from other infected sites
in the body through hematologic seeding and in these cases
it is labeled endogenous endophthalmitis. More common-
ly, the organism is exogenous and gains access to the intra-
ocular environment [2]. According to the Endophthalmitis
Vitrectomy Study, postoperative endophthalmitis is divided
generally into two types: acute and chronic. Acute post-
operative endophthalmitis is deﬁned as infections within 6
weeks of surgery; on the other hand, chronic postoperative
endophthalmitis is deﬁned as infections after 6 weeks of sur-
gery [3].
The term chronic postoperative endophthalmitis (CPE)
was ﬁrst coined in 1986 in a case series of 15 patients by
Meisler et al. [4]. The inﬂammation is usually indolent and
may persist for months. It is often misdiagnosed as nonin-
fectious iritis where it improves initially with topical corti-
costeroid therapy while ﬂaring whenever corticosteroids are
tapered or stopped [5]. This is in contrast to acute postoper-
ative endophthalmitis, which presents as a single episode of
severe inﬂammation with an acute onset that usually follows
surgery by a few days but can be delayed more than a week in
some cases. As such, acute and chronic postoperative endo-
phthalmitis are two clearly diﬀerent clinical entities [2, 4, 5].
2. Epidemiology
Postoperative endophthalmitis is an uncommon complica-
tion of any ocular surgery. The reported incidence of post-
operative endophthalmitis ranges from 0.01% to 0.367%,
with incidence varying among diﬀerent surgical procedures
and across studies and diﬀerent countries [1, 6–11]. Most
of postoperative endophthalmitis studies were conducted
on cases after cataract surgery, being the most commonly
performed surgery in ophthalmology [11]. In a large meta-
analysis, 3 140 650 cataract extraction cases were reviewed
for the incidence of endophthalmitis after cataract surgery
worldwide in the period between 1964 and 2003 [12].2 International Journal of Inﬂammation
The analysis showed an increase in the incidence of postsur-
gical endophthalmitis from 0.087% in the 1990s to 0.265%
in the 2000s, and this was attributed to the change in surgical
technique towards clear corneal sutureless wounds that allow
exogenous organisms easy access to the intraocular space.
Furthermore, postoperative endophthalmitis has been
reported after pars plana vitrectomy, penetrating kerato-
plasty, trabeculectomy, and glaucoma drainage device surg-
eries.Endophthalmitisalsohasbeenreportedfollowingexter
nal ocular surgeries such as scleral buckle, pterygium exci-
sion, and strabismus surgeries [11]. The highest endoph-
thalmitis rate was found in surgical procedures associated
with cataract extraction reaching 0.367%; on the other hand,
pars plana vitrectomy was found to have the lowest incidence
ratewithonly0.04%especiallyafterusingmicroincisiontech
nique [11, 13].
The data regarding the incidence of chronic postopera-
tive endophthalmitis are still lacking. But this form of post
operative endophthalmitis appears less common than the
acute variety [14]. Some reports estimated the ratio of acute
to chronic postoperative endophthalmitis to be between
5:1 and 2:1, indicating that the incidence rate of chronic
postoperative endophthalmitis can be 5 per 10000 [15]. In




tis tend to be diﬀerent from the acute form pathogens
[14]. They are usually indolent bacteria or fungus with low
virulence. CPE was originally considered to be a reaction to
the remaining native lens tissue and was consequently called
toxic lens syndrome or phacoanaphylactic endophthalmitis
[17]. However, studies of removed lens capsules revealed
small gram-positive rods, consistent with Propionibacterium
acnes, adherent to the capsular remnants [17].
A variety of organisms have been implicated in chronic
postoperative endophthalmitis (Table 1), with Propionibac-
terium species accounting for the majority of cases (41
to 63%) followed by coagulase-negative Staphylococcus and
fungus [5, 16, 18].
Propionibacterium acnes, formerly known as Corynebac-
terium parvum, is a variably staining, gram-positive, pleo-
morphic, and anaerobic bacillus. As its name suggests, P.
acnes is associated with chronic skin infections and with the
contamination of a variety of prosthetic devices [19, 20].
Despite being a potent stimulant of the immune system, P.
acnes is largely resistant to the killing mechanisms of mono-
cytes and neutrophils, which enables it to persist intra-cellu-
larly after phagocytosis [21].
Reviewing the largest three case series of CPE revealed
that 48% of the cases are caused by P. acnes, followed by fun-
gal organisms in 21% of the cases and gram-positive species
in 16% of the cases (Table 2).
Some case reports have also isolated Actinomyces, Nocar-
dia, Achromobacter, Cephalosporium, Acremonium, Paecilo-
myces, Ochrobactrum and Aspergillus species as causes of
Table 1: Infectious pathogens isolated in chronic postoperative
endophthalmitis [5, 16, 22–27].
Bacterial pathogens
Propionibacterium acnes Ochrobactrum anthropi
Staphylococcus species Hafnia alvei
Corynebacterium Sphingomona spaucimobilis
Nocardia Mycobacterium chelonae
Cephalosporium and Acremonium Pseudomonas stutzeri
Paecilomyces Achromobacter
Fungul pathogens
Aspergillus species Fonsecaea pedrosoi
Candida species Paecilomyces species
Curvularia lunata Acremonium strictum
Table 2: Percentage of organisms reported in diﬀerent case series of
chronic postoperative endophthalmitis [5, 18, 28].
Pathogens Shirodkar Al-Mezaine Fox Percentage
Propionibacterium acne 11 7 12 48.3%
Gram-positive species 3 3 4 16%
Gram-negative species 31 0 6 . 4 %
Mycobacteria 20 0 3 . 2 %
Fungal species 7 3 3 21.3%
Mixed 03 0 4 . 8 %
CPE [22, 29–31]. In some of these organisms such as
Staphylococcus epidermidis, and Propionibacterium acnes, the
clinical course of the disease may be aﬀected by factors such
as host characteristics or inoculum size [2, 5].
Routes of bacterial entry are believed to include intraop-
erative irrigation ﬂuids, surgical instruments, and inadver-
tently placing the intra-ocular lens on external ocular sur-
faces [32, 33]. The anterior chamber possesses an eﬃcient
mechanism of clearing small bacterial loads, so the currently
unexplainable failure of this mechanism may be one of a
multitudeofunknownfactorsinpostoperativebacterialend-
ophthalmitis [32, 34]. Known risk factors include vitreous
communication (e.g., through a posterior capsular tear or
YAG capsulotomy), certain IOL prosthetics, and diabetes
[35–38].
Fungal endophthalmitis is uncommon in the postoper-
ative setting, with most of the cases being attributable to
Candida species [5]. As such, most fungal endophthalmitis
cases are the result of infection by ﬁlamentous fungi, and a
minority is the result of molds [39]. Fungi possess resistant
cell walls that enable them to ﬂourish in the eye indeﬁnitely
shielded from immune attack and antibiotic therapy making
the management of these cases particularly challenging [40,
41].
4.Symptoms andClinicalFinding
The clinical picture of CPE is that of a recurrent and often
low-grade uveitis occurring months or even years after theInternational Journal of Inﬂammation 3
inciting surgical event. Uveitis typically starts two to three
months postoperatively and involves the anterior chamber
initially with progression to the vitreous as the disease
advances. Pain or discomfort may or may not be present in
CPE, while decreased vision is found in nearly all patients.
Inﬂammationisusuallysteroidresponsiveinitiallybutrecurs
after medication tapering, while it paradoxically worsens
with steroids in the case of some fungal infections [42]. The
clinical course in CPE is similar to that of phaeoantigenic
uveitisandhasbeensuggestedtobearesultofanimmunere-
action to the presence of both residual lens material and
bacteria [43, 44]. A slit lamp eye examination will reveal
white blood cells in the anterior chamber. The uveitis may be
granulomatouswithlargeprecipitatesonthecorneaorintra-
ocular lens and often without a frank hypopyon, but a
microhypopyon may be visible by gonioscopy. A white
intracapsular plaque representing retained lens particles and
sequestered organisms is highly suspicious of an infectious
process [14]. The plaque is commonly observed especially in
associationwithPropionibacterium speciesandlessfrequent-
ly with other bacterial or fungal infections [16, 29, 45, 46].
Vitreous activity is usually mild but can be dense and diﬀuse
particularly with Staphylococcus epidermidis [5]. CPE of fun-
gal etiology is usually characterized by “pearls-on-a-string”
or “ﬂuﬀ balls” near the capsular remnant and also with
stringy white inﬁltrates although both are not pathogno-
monic [5, 14].
5.DiagnosticApproach
The diagnosis of CPE is challenging given the diﬃculties
faced in isolating the causative organism. It is based on clin-
ical suspicion supported by cultures of the aqueous or post-
erior lens capsule or vitreous biopsy [47]. When CPE is sus-
pected, aqueous and/or vitreous samples should be obtained
for analysis. The sampling could be performed using needle
aspiration of 0.01mL of the aqueous ﬂuid or 0.02mL of
the vitreous. In case the vitreous needle aspiration was
not successful (dry tap), mechanical biopsy of the vitreous
through a pars plana vitrectomy could be performed. The
obtainedsampleshouldbeanalyzedwithgramstain,culture,
and identiﬁcation of antimicrobial sensitivities [14]. The
appropriate anaerobic medium should be used when nec-
essary and Giemsa and fungal cultures should be obtained
in case a fungus is suspected. The highest diagnostic yield
is achieved by sampling the white plaque in the posterior
lens capsule if present, utilizing a special culture medium, as
well as prolonging the culture time to several weeks to cover
the slow-growing organisms implicated in CPE [14, 48].
In culture negative cases, the additional use of polymerase
chain reaction was reported to aid in the identiﬁcation of the
organism [49]. The utilization of a universal bacterial primer
c o u l db eo fh e l pi nt h i ss e t t i n g .
CPE diﬀerential diagnosis spectrum includes noninfec-
tious causes such as lens-induced uveitis secondary to retain-
ed cortical material, IOL-induced uveitis secondary to im-
plant malposition causing iris chaﬁng and chronic inﬂam-
mation, and sympathetic ophthalmia or other causes of
uveitis unrelated to surgery [50, 51].
6.TreatmentStrategiesandOutcomes
The indolent nature of the organisms and their sequestration
within the capsule protected from host defenses along with
theirdiﬀerentvirulencefactorsmakeithardtodeﬁneatreat-
ment protocol for CPE or extrapolate the guidelines set for
acute postoperative endophthalmitis [14].
Diﬀerent modalities of treatment approaches have been
reported, and they range from (1) intraocular antibiotics
injection (IOAB) only to, (2) pars plana vitrectomy (PPV)
with IOAB to, (3) PPV with IOAB and partial capsulectomy
to, (4) PPV with IOAB and total capsulectomy with IOL re-
mo valorex change[5,16,18,28].Inaddition,someadvocate
waiting for culture, gram stain, and sensitivity data to allow
for directed therapy in cases where the inﬂammation is not
considered severe [2].
Two intraocular antibiotics injection approaches have
beendescribedeitherintothecapsularbagorsimultaneously
into the aqueous and the vitreous [52, 53].
Some reports suggest tailoring treatment options to the
severity of presenting signs and symptoms where mild cases
are to be managed with intraocular cultures followed by
intravitreal antibiotics while using repeated intraocular anti-
biotic and pars plana vitrectomy with partial capsulectomy
in recurrent cases [42]. Another approach depends on the
type of the isolated organism whereby S. epidermidis could
be treated with intraocular antibiotic injections alone while
P. acnes would require surgical intervention with pars plana
vitrectomy, capsulectomy and possible removal or exchange
of the IOL in addition to intraocular antibiotic injection [13,
20, 44]. This is based on the fact that multiple reports des-
cribed high rate of recurrence when P. acnes CPE was treated
with intravitreal antibiotics alone [20, 44].
Since at the time of the initial antibiotic injection the
organism is usually unknown, the initial approach to con-
siderintheempirictreatmentofchronicpostoperativeendo-
phthalmitis,whenfungalinfectionisnotsuspected,isintrav-
itreal vancomycin (1mg/0.1mL) owing to its broad coverage
of gram-positive bacteria and methicillin-resistant Staphylo-
cocci. P. acnes, the most commonly described causative org-
anism of CPE, is also sensitive to vancomycin but not to
aminoglycosides [14, 15]. It has also been reported to have
good susceptibility to carbapenems (meropenem and erta-
penem) in vitro [54]. Accordingly, the treatment should be
modiﬁed as sensitivity studies become available [15].On the
other hand, the beneﬁt of systemic and topical antibiotic use
remains controversial in CPE [14].
A cross-sectional review of four of the biggest case series
on delayed-onset endophthalmitis revealed diﬀerences in
outcomesthatcanbeattributedtocausativeorganism,initial
treatment modality, as well as the extent of intervention
[5, 16, 18, 28]. A total of 98 patients with CPE were reported
in these series. The overall visual outcome is calculated to be
20/40 or better in about 46% of the cases while 54% ended
upwithvaryingdegreesofvisualimpairment,allirrespective
of the stratifying factors mentioned above (Table 3).
All four case series indicate that an infection with P. acnes
or gram-positive organisms was associated with a better
visual outcome (better than 20/40 in 54.5% and 50% of4 International Journal of Inﬂammation
Table 3: Visual acuity outcomes reported in four major series of chronic postoperative endophthalmitis [5, 16, 18, 28].
VA outcome Fox (n = 19) Clark (n = 36) Al-Mezaine (n = 17) Shirodkar (n = 26) Overall (n = 98)
≥20/40 9 (47.3%) 18 (50%) 5 (29.4%) 13 (50%) 45 (45.9%)
20/50 ≥ 20/400 6 (31.5%) 10 (28%) 4 (23.5%) 6 (23%) 26 (26.5%)
<20/400 ≥ 5/200 1 (5.2%) 2 (5%) 2 (11.7%) 2 (7.7%) 7 (7.1%)
<5/200-NLP 3 (15.8%) 6 (17%) 6 (35%) 5 (19.2%) 20 (20.4%)
Table 4: Visual acuity outcomes by causative organism in chronic post operative endophthalmitis [5, 16, 18, 28].
Organism ≥20/40 20/50 ≥ 20/400 <20/400 ≥ 5/200 <5/200-NLP
P. acnes (n = 66) 36/66 (54.5%) 20/66 (30%) 2 (3%) 8/66 (12%)
Gram positive (n = 10) 5/10 (50%) 2/10 (20%) 1/10 (10%) 1/10 (10%)
Fungal (n = 13) 5/13 (38.5%) 3/13 (23%) 2/13 (15%) 3/13 (23%)
∗Others (n = 9) 1/9 (11%) 2/9 (22%) 0 6/9 (66.6%)
∗Others: gram-negative, mycoplasma, and mixed organisms.
Table 5: Recurrence rate of chronic post operative endophthalmitis with diﬀerent initial treatment modalities [5, 18, 28].
Initial treatment Fox (n = 19) Clark (n = 36) Shirodkar (n = 26) ∗Overall (n = 62)
IOAB only 4/5 (80%) 12/12 (100%) 2/3 (66%) 18/20 (90%)
PPV + IOAB 2/2 (100) 5/10 (50%) 8/10 (80%) 15/22 (68%)
PPV + PC+ IOAB 5/11 (45%) 2/14 (5.5%) 9/13 (69%) 16/38 (42%)
PPV + IOL exchange 0/1 (0%) None None 0/1 (0%)
∗AL-Mezaine review series was not included since it did not mention the recurrence rate after initial treatment.
Table 6: Recurrence rate of chronic post operative endophthalmitis with diﬀerent surgical interventions [5, 16, 18, 28].
Treatment modality∗ Fox (n = 19) Clark (n = 36) Al-Mezaine (n = 17) Shirodkar (n = 26) Overall (n = 98)
PPV + IOAB 5/7 (71%) 5/10 (50%) 1/3 (33.3%) 10/12 (83%) 15/22 (68%)
PPV + PC + IOAB 1/9 (11%) 4/21 (19%) 0 9/13 (69%) 14/43 (32%)
PPV + TC + IOL
exchange 0/4 (0%) 0/7 (0%) 0/4 (0%) 1/7 (14%) 1/22 (4.5%)
PPV + TC + no IOL 0 0/5 (0%) 0/1 (0%) 1/12 (8%) 1/18 (5.5%)
∗At any time of treatment (initial, secondary, or tertiary intervention).
the overall cases, resp.) (Table 4). Fungal infection was asso-
ciated with a more unfavorable prognosis where visual im-
pairment was precipitated in more than 60%, and more than
20%hadseverevisualimpairment (worsethan5/200). Inthe
same pool of patients, the recurrence rate diﬀered in relation
totheinitialtreatmentmodality(Table 5).Thehighestrecur-
rence was seen in cases where the initial treatment consisted
of antibiotics alone (90%). Starting therapy with pars plana
vitrectomy and antibiotics decreased the recurrence in all
series, while adding posterior capsulectomy to pars plana
vitrectomy and antibiotics as an initial management further
decreased the recurrence rate to 42%. As a trend, all case
series showed that recurrence rate decreased uniformly in
correlation with a more aggressive management strategy
(Table 6), whereby the overall calculated recurrence rate,
whencombinedPPV,IOAB,totalcapsulectomy,andremoval
or exchange of the IOL was performed at any time during
followup, decreased to as low as 5% compared to 68%
recurrence rate when PPV was combined with IOAB alone
(Table 6).
Chronic fungal postoperative endophthalmitis carries a
poor prognosis and there is no standard management avail-
able for treating this very rare condition. Current approach
includes pars plana vitrectomy, intravitreal amphotericin
(5–10mg/0.1mL) or voriconazole, and a systemic anti-
fungal drug [55–57]. The indolent course of the chronic
fungal postoperative endophthalmitis might beneﬁt from
prolonged systemic treatment with an antifungal (6 weeks–6
months) [57]. Topical antifungal agents (natamycin 5%) are
started when required, especially in cases of corneal involve-
ment [57].
In conclusion, chronic postoperative endophthalmitis
should always be in the diﬀerential of recurrent inﬂamma-
tion in a previously operated eye. A worsening course of in-
ﬂammation despite treatment is particularly alarming. Eﬀort
should be directed towards ﬁnding a deﬁnitive diagnosis in
this setting through obtaining intraocular samples for ana-
lysis early enough to institute aggressive treatment and avoid
recurrence and poor outcome.International Journal of Inﬂammation 5
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